Intussusception Market Growth Outlook Through 2024-2033

Overview and Scope
Intussusception is a medical condition in which one portion of the intestine slides into an adjacent section of the intestine, blocking the flow of food, fluids, and gas through the affected part of the intestine, leading to symptoms such as severe abdominal pain, vomiting, and bloody stools. It is usually diagnosed based on the symptoms, physical examination, and imaging tests.

Sizing and Forecast
The intussusception market size has grown strongly in recent years. It will grow from $4.22 billion in 2023 to $4.45 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to improved diagnostic capabilities, increased awareness and education, global healthcare infrastructure growth, research and development investments, collaboration among healthcare entities..

The intussusception market size is expected to see steady growth in the next few years. It will grow to $5.3 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to continued medical education initiatives, pediatric vaccination programs, global efforts in pediatric healthcare, focus on postoperative care, rising demand for pediatric gastrointestinal research, telemedicine and remote healthcare access.. Major trends in the forecast period include advancements in diagnostic imaging, minimally invasive treatment approaches, development of pediatric-specific interventions, research on etiology and risk factors, global epidemiological studies, implementation of vaccination programs, telemedicine for diagnosis and consultation..

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/intussusception-global-market-report

Segmentation & Regional Insights
The intussusception market covered in this report is segmented –

1) By Type: Idiopathic Intussusception, Secondary Intussusception
2) By Treatment: Enema Reduction, Surgery, Other Treatment
3) By Diagnosis: Barium Enema, Ultrasound, X-Ray, Computerized Tomography (CT)
4) By End-User: Hospitals, Clinics, Other End-User

North America was the largest region in the intussusception market in 2023. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13466&type=smp

Major Driver Impacting Market Growth
The rising incidence of intestinal disorders is expected to propel the growth of the intussusception market going forward. An intestinal disorder refers to any medical condition or health issue that affects the normal functioning of the intestines, which are parts of the digestive system responsible for absorbing nutrients and eliminating waste from the body. An increasing incidence of intestinal disorders such as inflammatory bowel disease and gastrointestinal cancers can lead to earlier diagnosis, improved treatment options, and enhanced support for intussusception patients, ultimately benefiting their health and well-being. For instance, in January 2023, according to the American Cancer Society (ACS), a US-based health organization dedicated to eliminating cancer, gastrointestinal cancers increased by 3.18% to 348,840 compared to 338,090 in 2021 in the United States. Therefore, the rising incidence of intestinal disorders will drive the growth of the intussusception market.

Key Industry Players
Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline plc, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc. , Steris Plc, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc. , Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.</b

The intussusception market report table of contents includes:

1. Executive Summary
2. Intussusception Market Characteristics
3. Intussusception Market Trends And Strategies
4. Intussusception Market – Macro Economic Scenario
5. Global Intussusception Market Size and Growth
.
.
.
32. Global Intussusception Market Competitive Benchmarking
33. Global Intussusception Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Intussusception Market
35. Intussusception Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model